Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Volker Schirrmacher

doi:10.1007/s00262-004-0602-0

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Cancer Immunology Immunotherapy ◽

10.1007/s00262-004-0602-0 ◽

2004 ◽

Vol 54 (6) ◽

pp. 587-598 ◽

Cited By ~ 78

Author(s):

Volker Schirrmacher

Keyword(s):

Clinical Trials ◽

Virus Infection ◽

Tumor Cell ◽

Patient Survival ◽

Immune Memory ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

Improvements of Survival in Nine Phase II Clinical Studies with Different Types of Cancer Upon Anti- Tumor Vaccination with an Autologous Tumor Cell Vaccine Modified by Virus Infection to Introduce Danger Signals

Advances in Experimental Medicine and Biology - New Trends in Cancer for the 21stCentury ◽

10.1007/978-1-4615-0081-0_14 ◽

2003 ◽

pp. 175-193 ◽

Cited By ~ 1

Author(s):

Volker Schimnaker

Keyword(s):

Virus Infection ◽

Tumor Cell ◽

Phase Ii ◽

Clinical Studies ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Danger Signals ◽

Autologous Tumor Cell Vaccine

Download Full-text

Anti-metastatic activity of hapten-modified autologous tumor cell vaccine in an animal tumor model

Cancer Immunology Immunotherapy ◽

10.1007/s00262-002-0271-9 ◽

2002 ◽

Vol 51 (4) ◽

pp. 200-208 ◽

Cited By ~ 9

Author(s):

Dorothy K. Sojka, Diana Felnerova, Margalit

Keyword(s):

Tumor Cell ◽

Tumor Model ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Animal Tumor ◽

Metastatic Activity ◽

Autologous Tumor Cell Vaccine

Download Full-text

Phase II study of B7–1 gene-modified autologous tumor cell vaccine and subcutaneous IL-2 for patients with stage IV renal cell carcinoma (RCC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4502 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4502-4502 ◽

Cited By ~ 2

Author(s):

P. Thompson ◽

M. Fishman ◽

J. Seigne ◽

M. Dunn ◽

W. Janssen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tumor Cell ◽

Renal Cell ◽

Phase Ii Study ◽

Stage Iv ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

241. TAG Vaccine: Autologous Tumor Cell Vaccine Genetically Modified To Express GM-CSF and Block Expression of TGFbeta2 – Preclinical Development, Manufacturing and Early Clinical Data

Molecular Therapy ◽

10.1016/s1525-0016(16)39644-7 ◽

2008 ◽

Vol 16 ◽

pp. S91

Keyword(s):

Tumor Cell ◽

Clinical Data ◽

Genetically Modified ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Preclinical Development ◽

Gm Csf ◽

Autologous Tumor Cell Vaccine

Download Full-text

187. Randomized Phase II Trial of Post-Operative Adjuvant Chemotherapy ±FANG™ Autologous Tumor Cell Vaccine in Colorectal Carcinoma with Liver Metastases

Molecular Therapy ◽

10.1016/s1525-0016(16)35991-3 ◽

2012 ◽

Vol 20 ◽

pp. S74

Keyword(s):

Adjuvant Chemotherapy ◽

Colorectal Carcinoma ◽

Tumor Cell ◽

Phase Ii Trial ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Randomized Phase Ii ◽

Autologous Tumor Cell Vaccine

Download Full-text

Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.003 ◽

2015 ◽

Vol 137 ◽

pp. 2-3 ◽

Cited By ~ 2

Author(s):

J. Oh ◽

M. Barve ◽

E.A. Grosen ◽

B.A. Fine ◽

T.P. Heffernan ◽

...

Keyword(s):

Ovarian Cancer ◽

Tumor Cell ◽

Phase Ii Trial ◽

Complete Response ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Randomized Phase Ii ◽

Autologous Tumor Cell Vaccine

Download Full-text

Bi-shRNA-Furin/GM-CSF-Expressing Autologous Tumor Cell Vaccine

10.32388/mvxxgd ◽

2020 ◽

Author(s):

Keyword(s):

Tumor Cell ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Gm Csf ◽

Autologous Tumor Cell Vaccine

Download Full-text

FANG Vaccine: Autologous Tumor Cell Vaccine Genetically Modified to Express GM-CSF and Block Production of Furin

BioProcessing Journal ◽

10.12665/j84.maples ◽

2010 ◽

Vol 8 (4) ◽

pp. 4-14 ◽

Cited By ~ 17

Author(s):

Phillip Maples ◽

Padmasini Kumar ◽

Yang Yu ◽

Zhaohui Wang ◽

Chris Jay ◽

...

Keyword(s):

Tumor Cell ◽

Genetically Modified ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Gm Csf ◽

Autologous Tumor Cell Vaccine

Download Full-text

Antitumor Immunization of Head and Neck Squamous Cell Carcinoma Patients with a Virus-Modified Autologous Tumor Cell Vaccine

Advances in Oto-Rhino-Laryngology - Current Research in Head and Neck Cancer ◽

10.1159/000082507 ◽

2004 ◽

pp. 173-183 ◽

Cited By ~ 1

Author(s):

Christel Herold-Mende ◽

Jochen Karcher ◽

Gerhard Dyckhoff ◽

Volker Schirrmacher

Keyword(s):

Squamous Cell Carcinoma ◽

Tumor Cell ◽

Cell Carcinoma ◽

Head And Neck ◽

Neck Squamous Cell Carcinoma ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text

FANG: bi-shRNAifurin and GMCSF DNA-Augmented Autologous Tumor Cell Vaccine: Clinical Results

Gene and Cell Therapy ◽

10.1201/b18002-51 ◽

2015 ◽

pp. 1073-1090

Author(s):

John Nemunaitis ◽

Donald Rao ◽

Neil Senzer

Keyword(s):

Tumor Cell ◽

Clinical Results ◽

Cell Vaccine ◽

Autologous Tumor Cell ◽

Autologous Tumor ◽

Tumor Cell Vaccine ◽

Autologous Tumor Cell Vaccine

Download Full-text